InvestorsHub Logo

Here Today

06/20/20 11:26 AM

#303574 RE: attilathehunt #303568

I look at it this way - Gilead with Remdesivir is expecting $7 Billion in annual revenue to start for use against Covid19 and their drug is not that effective.

If Brilacidin proves out in human trials against Covid19 and other viruses, what do you think the annual revenue will be??? My opinion - 10’s of Billions!

petemantx

06/20/20 11:45 AM

#303583 RE: attilathehunt #303568

petemantx

06/20/20 11:46 AM

#303584 RE: attilathehunt #303568

Your thinking shows you haven't been around long. CEO, who has total control of a buyout, won't be selling at that time unless someone coughs up many, many billions and it seems too early for that to happen yet.

Maybe in the next 2 years, but Brilacidin has a long way to go to show its full power and revenue-producing potential. Why sell now when it will only get much more valuable in the future?

CEO is not a trader or interested in getting richer (as he knows he already is mega rich with IPIX today) so don't expect a quick sale.

As I posted a while back, you don't sell a gold mine after you find the first big nugget. You have to analyze the whole field before determining when to sell and for how much.